Showing 4,141 - 4,160 results of 5,085 for search '"cardiovascular"', query time: 0.09s Refine Results
  1. 4141

    Influence of Hypertension on Neurocognitive Domains in Nondemented Parkinson’s Disease Patients by Jacob D. Jones, Charles Jacobson, Martina Murphy, Catherine Price, Michael S. Okun, Dawn Bowers

    Published 2014-01-01
    “…Health comorbidities, particularly cardiovascular risk factors, are well known to pose risks for cognitive decline in older adults. …”
    Get full text
    Article
  2. 4142

    Increased Risk of Atrial and Ventricular Arrhythmia in Long-Lasting Psoriasis Patients by Hakki Simsek, Musa Sahin, Aytac Akyol, Serkan Akdag, Hatice Uce Ozkol, Hasan Ali Gumrukcuoglu, Yilmaz Gunes

    Published 2013-01-01
    “…Several reports have demonstrated an association between psoriasis and cardiovascular diseases. P wave dispersion (PWD) is the most important electrocardiographic (ECG) markers used to evaluate the risk of atrial arrhythmias. …”
    Get full text
    Article
  3. 4143

    Conducting genetic epidemiology research on hyperuricaemia and gout in an indigenous community in Guam - a feasibility study by Yvette C. Paulino, Frank Camacho, Tristan VC Paulino, Delores J. Lee, Lisa Linda Natividad, Elizabeth Matisoo-Smith, Tony R. Merriman, Anna L. Gosling

    Published 2025-02-01
    “…The prevalence of metabolic conditions from highest to lowest were obesity (55.6%), hyperuricaemia (36.0%), hypertension (27.8%), gout (23.0%), diabetes (14.9%), cardiovascular disease (8.4%), kidney disease (7.3%), and liver disease (3.4%). …”
    Get full text
    Article
  4. 4144

    Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life by Urszula Religioni, Rocío Barrios-Rodríguez, Pilar Requena, Mariola Borowska, Janusz Ostrowski

    Published 2025-01-01
    “…Adherence to therapy, defined as the extent to which a patient follows prescribed therapeutic recommendations, is a pivotal factor in the effective management of chronic diseases such as diabetes, hypertension, and cardiovascular conditions. This review highlights the profound influence of adherence on clinical outcomes, healthcare costs, and patient quality of life. …”
    Get full text
    Article
  5. 4145

    Diabetes Treatment with Dapagliflozin and Its Combinations: Insights from Clinical Practice by Akshay Bafna, Ajit Mehta, Rajeev Garg, Jayagopal Pathiyil Balagopalan, Rajesh Rajput, Nitin Zalte, Preethi Naik, Amarnath Sugumaran, Senthilnathan Mohanasundaram

    Published 2024-04-01
    “…According to 90.93% and 47.19% of clinicians, most patients with T2DM were in the age group of 40–60 years, and cardiovascular (CV) risk is present in 3 in 10 of T2DM patients, respectively. …”
    Get full text
    Article
  6. 4146

    Evolving View of Coronary Artery Calcium: A Personalized Shared Decision-Making Tool in Primary Prevention by Omar Dzaye, Cara Reiter-Brennan, Albert D. Osei, Olusola A. Orimoloye, S. M. Iftekhar Uddin, Mohammadhassan Mirbolouk, Michael J. Blaha

    Published 2019-01-01
    “…Specifically, the current prevention guideline recommends CAC testing for primary atherosclerotic cardiovascular disease (ASCVD) prevention among asymptomatic patients in borderline and intermediate risk groups (5–7.5% and 7.5–20% 10-year ASCVD risk). …”
    Get full text
    Article
  7. 4147

    Structural and vascular assessment of the optic nerve head and macula in chronic Chagas disease by Cristiana L. M. Agra, Camila V. Ventura, Letícia D. da Fonte, Marcela R. V. Oliveira, Marília Leal, Maria Elisa L. S. M. Assunção, Maria da Glória A. M. Cavalcanti, Silvia M. M. Alves, Ana Karine Soares, Liana O. Ventura, Tiago S. Prata

    Published 2025-01-01
    “…Although our findings suggested that the cardiovascular dysfunction resulting from chronic CD does not seem to cause significant structural or vascular preclinical changes to the ONH and the macula, the results herein benefit this patient population and may provide important preliminary information about the ocular impairment caused by the condition and its possible systemic complications.…”
    Get full text
    Article
  8. 4148

    Blood Pressure Exploration in the November 27th Health Area Population from Marianao Municipality by Moura Revueltas Aguero, Yamilé Valdés González, Silvia Serra Larín, Carlos Barceló Pérez, Juan Carlos Ramírez Sotolongo, Ramón Suárez Medina

    Published 2020-09-01
    “…High blood pressure can be a direct cause of death, but it is also the cardiovascular risk factor that causes the most deaths. …”
    Get full text
    Article
  9. 4149

    Mean Platelet Volume in Ocular Behçet’s Disease by Fatih Mehmet Türkcü, Abdullah Kürşat Cingü, Harun Yüksel, Yasin Çınar, Meltem Akkurt, Muhammed Şahin, Zeynep Özkurt, Alparslan Şahin, İhsan Çaça

    Published 2013-01-01
    “…These patients had no past history of smoking, drug use, or systemic diseases including diabetes mellitus, hypertension, cardiovascular disease, and renal disease. A control group consisting of 34 healthy individuals was included for comparison. …”
    Get full text
    Article
  10. 4150

    Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation by Derralynn Hughes, Andrew Lenny, Koonal Shah, Louise Longworth, Giovanna Devercelli, Olulade Ayodele

    Published 2023-04-01
    “…The interviewees' responses, evidence from published literature, and input from a clinical expert informed the development of 6 health state vignettes (pain, moderate clinically evident FD \[CEFD\], severe CEFD, end-stage renal disease \[ESRD\], stroke, and cardiovascular disease \[CVD\]) and 3 combined health states (severe CEFD + ESRD, severe CEFD + CVD, and severe CEFD + stroke). …”
    Get full text
    Article
  11. 4151
  12. 4152

    Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus by A. E. Bagriy, A. D. Zubov, M. V. Khomenko, E. S. Mikhailichenko, E. A. Pylaeva, N. A. Khaustova, E. V. Bryukhovetskaya

    Published 2021-06-01
    “…NAFLD is associated with an increased cardiovascular risk (due to association with “metabolic syndrome”) and the risks of liver cirrhosis and hepatocellular carcinoma. …”
    Get full text
    Article
  13. 4153
  14. 4154

    Prevalence, Awareness, Treatment, and Control of Hypertension and Its Associated Risk Factors: Results from Baseline Survey of SWADES Family Cohort Study by M. D. Saju, Komal Preet Allagh, Lorane Scaria, Shinto Joseph, Jotheeswaran Amuthavalli Thiyagarajan

    Published 2020-01-01
    “…Hypertension is one of the most important modifiable risk factors for cardiovascular diseases. The objective of this study is to estimate the prevalence, awareness, treatment, and control of hypertension and its associated risk factors in Ernakulam district, Kerala. …”
    Get full text
    Article
  15. 4155

    Effects of 6 Months of Active Commuting and Leisure-Time Exercise on Fibrin Turnover in Sedentary Individuals with Overweight and Obesity: A Randomised Controlled Trial by Anne Sofie Gram, Martin Bæk Petersen, Jonas Salling Quist, Mads Rosenkilde, Bente Stallknecht, Else-Marie Bladbjerg

    Published 2018-01-01
    “…Obesity and exercise constitute important factors for cardiovascular disease risk, but the long-term effects of different exercise modalities on haemostatic biomarkers are not well elucidated. …”
    Get full text
    Article
  16. 4156

    Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes by Bethany Murphy, Simran Chahal, Elleigh Shepherd, Nicole Taylor, Austin Camp

    Published 2025-01-01
    “…Purpose: In the treatment of type 2 diabetes mellitus (T2DM), select sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are recommended based on comorbidities such as chronic kidney disease (CKD), heart failure (HF), and atherosclerotic cardiovascular disease (ASCVD). Because guidelines typically recommend insulin for inpatient treatment of T2DM, there is potential these therapies may be negatively impacted by hospitalization. …”
    Get full text
    Article
  17. 4157

    The Effect of Aerobic Training on Weight Loss in Middle-Aged and Older Adults: Is It a Sufficient Form of Exercise? by Anita Ptak, Michał Szyc

    Published 2025-01-01
    “…Overweight and obesity are risk factors for many diseases, including cardiovascular diseases and diabetes. Many papers have been produced investigating the effects of different types of training and diet on body fat levels in overweight and obese populations. …”
    Get full text
    Article
  18. 4158

    Regular Consumption of a Flavanol-rich Chocolate can Improve Oxidant Stress in Young Soccer Players by Cesar G. Fraga, Lucas Actis-Goretta, Javier I. Ottaviani, Fernando Carrasquedo, Silvina B. Lotito, Sheryl Lazarus, Harold H. Schmitz, Carl L. Keen

    Published 2005-01-01
    “…In conclusion, FCMC consumption was associated with changes in several variables often associated with cardiovascular health and oxidant stress. …”
    Get full text
    Article
  19. 4159

    GLIM criteria for definition of malnutrition in peritoneal dialysis: a new aspect of nutritional assessment by Dao Wang, Jun Yin, Wen Liao, Xiaoran Feng, Fengping Zhang

    Published 2024-12-01
    “…In sensitivity analyses, the HR remained robust except the cardiovascular disease subgroup. The area under the curve of GLIM predicting 5-year mortality was 0.65 (0.62–0.68, p < 0.001). …”
    Get full text
    Article
  20. 4160